Zhirui Zhu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Zhirui Zhu has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
Chenjia Jiang
Department of Anesthesiology Children's Hospital, Zhejiang University School of Medicine Hangzhou China
1 shared publicationDongpi Wang
Department of Anesthesiology, Children’s Hospital, Zhejiang University School of Medicine, Hangzhou, China
1 shared publication- Feihong Mb Li
Department of Anesthesiology, Children’s Hospital, Zhejiang University School of Medicine, Hangzhou, China
1 shared publication Hongfei Lin
Department of Anesthesiology, Children’s Hospital, Zhejiang University School of Medicine, Hangzhou, China
1 shared publication- Jian Mb Tang
Department of Anesthesiology, Children’s Hospital, Zhejiang University School of Medicine, Hangzhou, China
1 shared publication - Jiangmei Wang
School of Resource and Civil Engineering, Northeastern University, Shenyang 110819, China
1 shared publication
Latest Publications
- Open Access
- 17 December 2024
- Published by Wiley in Clinical Case Reports
- Vol. 12 (12)
A Chinese Girl With LIG4 Syndrome and Hematopoietic Stem Cell Transplantation: A Rare Case Report and Review of the Literature
LIG4 syndrome is an exceptionally rare primary immune deficiency. It is an autosomal recessive genetic disease, falling within the spectrum of genetic disorders characterized by impaired DNA damage response mechanisms. Common clinical characteristics encompass microcephaly, growth retardation, developmental delays, facial deformities, variable immune deficiencies, pancytopenia, heightened susceptibility to malignant tumors, and significant clinical and cellular radiosensitivity. Hematopoietic stem cell transplantation (HSCT) is a curative treatment for LIG4 syndrome and may mitigate the long‐term risk of developing lymphoid malignancies by improving tumor surveillance.
- 17 December 2024
- Published by Wiley in Clinical Case Reports
- Vol. 12 (12)
Open AccessA Chinese Girl With LIG4 Syndrome and Hematopoietic Stem Cell Transplantation: A Rare Case Report and Review of the Literature
LIG4 syndrome is an exceptionally rare primary immune deficiency. It is an autosomal recessive genetic disease, falling within the spectrum of genetic disorders characterized by impaired DNA damage response mechanisms. Common clinical characteristics encompass microcephaly, growth retardation, developmental delays, facial deformities, variable immune deficiencies, pancytopenia, heightened susceptibility to malignant tumors, and significant clinical and cellular radiosensitivity. Hematopoietic stem cell transplantation (HSCT) is a curative treatment for LIG4 syndrome and may mitigate the long‐term risk of developing lymphoid malignancies by improving tumor surveillance.
- Open Access
- 9 February 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (6) , e36034
NAA10 gene related Ogden syndrome with obstructive hypertrophic cardiomyopathy: A rare case report
Rationale: Ogden syndrome is an exceptionally rare X-linked disease caused by mutations in the NAA10 gene. Reported cases of this syndrome are approximately 20 children and are associated with facial dysmorphism, growth delay, developmental disorders, congenital heart disease, and arrhythmia. Patient concerns: We present the clinical profile of a 3-year-old girl with Ogden syndrome carrying a de novo NAA10 variant [NM_003491:c.247C>T, p.(Arg83Cys)]. During infancy, she exhibited features such as left ventricular hypertrophy, protruding eyeballs, and facial deformities. Diagnosis: Clinical diagnosis included Ogden syndrome, congenital heart disease (obstructive hypertrophic cardiomyopathy, left ventricular outflow tract obstruction, mitral valve disease, tricuspid valve regurgitation), tonsillar and adenoidal hypertrophy, and speech and language delay. Interventions: The girl was considered to have hypertrophic cardiomyopathy (HCM) and received oral metoprolol as a treatment for HCM at our hospital. The drug treatment effect was not ideal, and her hypertrophy myocardial symptoms were aggravated and she had to be hospitalized for surgery. Outcomes: The girl underwent a modified Morrow procedure under cardiopulmonary bypass and experienced a favorable postoperative recovery. No pulmonary infections or significant complications were observed during this period. The patient’s family expressed satisfaction with the treatment process. Lessons: The case emphasizes the HCM of Odgen syndrome, and early surgery should be performed if drug treatment is ineffective.
- 9 February 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (6) , e36034
Open AccessNAA10 gene related Ogden syndrome with obstructive hypertrophic cardiomyopathy: A rare case report
Rationale: Ogden syndrome is an exceptionally rare X-linked disease caused by mutations in the NAA10 gene. Reported cases of this syndrome are approximately 20 children and are associated with facial dysmorphism, growth delay, developmental disorders, congenital heart disease, and arrhythmia. Patient concerns: We present the clinical profile of a 3-year-old girl with Ogden syndrome carrying a de novo NAA10 variant [NM_003491:c.247C>T, p.(Arg83Cys)]. During infancy, she exhibited features such as left ventricular hypertrophy, protruding eyeballs, and facial deformities. Diagnosis: Clinical diagnosis included Ogden syndrome, congenital heart disease (obstructive hypertrophic cardiomyopathy, left ventricular outflow tract obstruction, mitral valve disease, tricuspid valve regurgitation), tonsillar and adenoidal hypertrophy, and speech and language delay. Interventions: The girl was considered to have hypertrophic cardiomyopathy (HCM) and received oral metoprolol as a treatment for HCM at our hospital. The drug treatment effect was not ideal, and her hypertrophy myocardial symptoms were aggravated and she had to be hospitalized for surgery. Outcomes: The girl underwent a modified Morrow procedure under cardiopulmonary bypass and experienced a favorable postoperative recovery. No pulmonary infections or significant complications were observed during this period. The patient’s family expressed satisfaction with the treatment process. Lessons: The case emphasizes the HCM of Odgen syndrome, and early surgery should be performed if drug treatment is ineffective.
- Open Access
- 19 March 2020
- Published by BMJ in World Journal of Pediatric Surgery
- Vol. 3 (1) , e000126
Recommendation about the perioperative prevention of infection to healthcare workers and the anesthesia management of children with SARS-CoV-2 infection
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread widely and persistently over 100 countries. New challenges have occurred in the perioperative management of airway and anesthesia in children diagnosed with SARS-CoV-2 infection. According to current publications and to our own experiences in anesthesia management for cases with SARS-CoV-2 suspected, we reviewed concerns about the perioperative prevention of SARS-CoV-2 to medical staff and the anesthesia strategy to the patient.
- 19 March 2020
- Published by BMJ in World Journal of Pediatric Surgery
- Vol. 3 (1) , e000126
Open AccessRecommendation about the perioperative prevention of infection to healthcare workers and the anesthesia management of children with SARS-CoV-2 infection
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread widely and persistently over 100 countries. New challenges have occurred in the perioperative management of airway and anesthesia in children diagnosed with SARS-CoV-2 infection. According to current publications and to our own experiences in anesthesia management for cases with SARS-CoV-2 suspected, we reviewed concerns about the perioperative prevention of SARS-CoV-2 to medical staff and the anesthesia strategy to the patient.